Quick navigation menu :
  1. Go to content
  2. Go to the main sections menu
  3. Go to the subsections menu
  4. Go to the search engine
  5. Go to the languages menu
  6. Go to the help menu
  7. Go to the slots
  8. Go to contact slot
You are here:
  1. Home
  2. > Press room
  3. > Press packs
  4. > By year
  5. > Year 2002
Languages menu :
 

Contacts

Press Relations
Tel. :
(33) 1 53 77 4450
Fax :
(33) 1 53 77 4622
Adress :
174, avenue de France
75013 PARIS
FRANCE
Switchboard :
(33) 1 53 77 4000
 Content :

Press packs 2002

Attention(temp en dur) Press releases and press packs are intended to journalists, investors and shareholders.  

November 20, 2002 New perspectives on the long-term reduction of ischemic events post coronary intervention.

September 5, 2002 Exploring new frontiers in hypertension and type 2 diabetes - irbesartan.

September 3, 2002 Perspectives on the protective role of irbesartan in renal and cardiovascular disease.

September 2, 2002 New horizons for clopidogrel in the treatment of atherothrombosis.

July 1, 2002 Sanofi-Synthélabo listed on the NYSE.

May 29, 2002 Role of Clopidogrel in the long-term prevention of ischemic stroke (MATCH Study)

March 18, 2002 New perspectives on Clopidogrel in the management of acute and long-term risks of atherothrombosis.

© sanofi-aventis 2004-2008 | Legal notice | Update: July 11, 2008